{"id":7506,"date":"2024-08-31T13:09:02","date_gmt":"2024-08-31T05:09:02","guid":{"rendered":"https:\/\/regask.com\/?p=7506"},"modified":"2024-09-25T02:19:23","modified_gmt":"2024-09-24T18:19:23","slug":"atelier-sur-les-medicaments-generiques-de-la-fda-2024","status":"publish","type":"post","link":"https:\/\/regask.com\/fr\/fda-2024-generic-drug-workshop\/","title":{"rendered":"Programme 2024 de la FDA am\u00e9ricaine pour faire progresser le d\u00e9veloppement de m\u00e9dicaments g\u00e9n\u00e9riques\u2026"},"content":{"rendered":"<p>Le Centre d&#039;\u00e9valuation et de recherche des m\u00e9dicaments (CDER) de la FDA et l&#039;assistance aux petites entreprises et \u00e0 l&#039;industrie (SBIA) accueilleront le tr\u00e8s attendu atelier 2024 sur l&#039;avancement du d\u00e9veloppement des m\u00e9dicaments g\u00e9n\u00e9riques les 24 et 25 septembre 2024.<\/p>\n<p>Cet atelier est une occasion incontournable pour les professionnels de l&#039;industrie des m\u00e9dicaments g\u00e9n\u00e9riques de se tenir inform\u00e9s des derni\u00e8res avanc\u00e9es scientifiques et r\u00e9glementaires. Qu&#039;ils y participent en personne ou virtuellement, les participants repartiront avec des informations exploitables et une meilleure compr\u00e9hension du paysage futur du d\u00e9veloppement des m\u00e9dicaments g\u00e9n\u00e9riques.<\/p>\n<p><strong>Domaines d&#039;int\u00e9r\u00eat de l&#039;atelier<\/strong><\/p>\n<p>L&#039;atelier abordera des sujets cruciaux essentiels \u00e0 l&#039;avancement de l&#039;industrie des m\u00e9dicaments g\u00e9n\u00e9riques, notamment :<\/p>\n<ul>\n<li><strong>Progr\u00e8s dans la caract\u00e9risation in vitro<\/strong>:D\u00e9couvrez les derni\u00e8res m\u00e9thodologies am\u00e9liorant la caract\u00e9risation in vitro des m\u00e9dicaments g\u00e9n\u00e9riques.<\/li>\n<li><strong>Recherche pour le d\u00e9veloppement de l&#039;orientation<\/strong>: Comprendre les initiatives de recherche de la FDA visant \u00e0 \u00e9laborer des directives pour les produits complexes.<\/li>\n<li><strong>Assurer la qualit\u00e9 et l&#039;efficacit\u00e9<\/strong>:D\u00e9couvrez les efforts en cours pour assurer le d\u00e9veloppement efficace et la haute qualit\u00e9 des m\u00e9dicaments g\u00e9n\u00e9riques.<\/li>\n<\/ul>\n<p>Les participants acquerront \u00e9galement une compr\u00e9hension plus approfondie de l&#039;impact du programme scientifique et de recherche sur les modifications des frais d&#039;utilisation des m\u00e9dicaments g\u00e9n\u00e9riques (GDUFA) de la FDA sur le d\u00e9veloppement, la r\u00e9glementation et l&#039;approbation des m\u00e9dicaments g\u00e9n\u00e9riques.<\/p>\n<p><strong>Programme des ateliers<\/strong><\/p>\n<ul>\n<li><strong>Jour 1<\/strong>: 24 septembre 2024, de 8 h 30 \u00e0 16 h 35 HE<\/li>\n<li><strong>Jour 2<\/strong>: 25 septembre 2024, de 9h00 \u00e0 16h15 HE<\/li>\n<\/ul>\n<a href=\"https:\/\/regask.com\/fr\/contact-2\/\" target=\"_blank\" class=\"button primary is-link is-medium\" rel=\"noopener\" >\n\t\t<span>Pour en savoir plus<\/span>\n\t<\/a>\n\n<p>\u00a9Cette RegAlert est \u00e9mise par RegASK<\/p>","protected":false},"excerpt":{"rendered":"<p>The FDA&#8217;s Center for Drug Evaluation and Research (CDER) Small Business and Industry Assistance (SBIA) is set to host the highly anticipated 2024 Advancing Generic Drug Development Workshop on September 24-25, 2024. This workshop is an essential opportunity for professionals in the generic drug industry to stay informed on the latest scientific and regulatory advancements&#8230;.<\/p>","protected":false},"author":22,"featured_media":7511,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[35],"tags":[177,193,299,481,482,483],"class_list":["post-7506","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-biotech-latest-insights","tag-labelling","tag-fda","tag-regulatory-intelligence","tag-generic-drugs","tag-webinar","tag-workshop"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v28.0 (Yoast SEO v28.3) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>FDA&#039;s 2024 Generic Drug Workshop: Key Insights | RegASK<\/title>\n<meta name=\"description\" content=\"The FDA&#039;s 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/regask.com\/fr\/atelier-sur-les-medicaments-generiques-de-la-fda-2024\/\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"US FDA&#039;s 2024 Advancing Generic Drug Development Workshop: A Must-Attend Event for Industry Professionals\" \/>\n<meta property=\"og:description\" content=\"The FDA&#039;s 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/regask.com\/fr\/atelier-sur-les-medicaments-generiques-de-la-fda-2024\/\" \/>\n<meta property=\"og:site_name\" content=\"RegASK\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/\" \/>\n<meta property=\"article:published_time\" content=\"2024-08-31T05:09:02+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-09-24T18:19:23+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1600\" \/>\n\t<meta property=\"og:image:height\" content=\"1200\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Divvya Behal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:site\" content=\"@ASKRegASK\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Divvya Behal\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"},\"author\":{\"name\":\"Divvya Behal\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\"},\"headline\":\"US FDA&#8217;s 2024 Advancing Generic Drug Development &hellip;\",\"datePublished\":\"2024-08-31T05:09:02+00:00\",\"dateModified\":\"2024-09-24T18:19:23+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"},\"wordCount\":232,\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"keywords\":[\"Labelling\",\"FDA\",\"Regulatory Intelligence\",\"Generic Drugs\",\"Webinar\",\"Workshop\"],\"articleSection\":[\"Pharma and Biotech\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\",\"name\":\"FDA's 2024 Generic Drug Workshop: Key Insights | RegASK\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"datePublished\":\"2024-08-31T05:09:02+00:00\",\"dateModified\":\"2024-09-24T18:19:23+00:00\",\"description\":\"The FDA's 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.\",\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/fda-2024-generic-drug-workshop\\\/#primaryimage\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/08\\\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png\",\"width\":1600,\"height\":1200,\"caption\":\"Us Fda 2024 Advancing Generic Drug Development Workshop Must Attend Event Industry Professionals\"},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/regask.com\\\/#website\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"name\":\"RegASK\",\"description\":\"The Regulatory AI Operating System for High-Performing Teams\",\"publisher\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/regask.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/regask.com\\\/#organization\",\"name\":\"RegASK\",\"url\":\"https:\\\/\\\/regask.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"contentUrl\":\"https:\\\/\\\/regask.com\\\/wp-content\\\/uploads\\\/2024\\\/10\\\/RegASK-Logo-Dark-Round.png\",\"width\":401,\"height\":401,\"caption\":\"RegASK\"},\"image\":{\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/RegASKRegulatoryAffairs\\\/\",\"https:\\\/\\\/x.com\\\/ASKRegASK\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/RegASK\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@RegASK\",\"https:\\\/\\\/www.crunchbase.com\\\/organization\\\/regask\",\"https:\\\/\\\/www.bloomberg.com\\\/profile\\\/company\\\/1691237D:SP\",\"https:\\\/\\\/pitchbook.com\\\/profiles\\\/company\\\/265004-02\",\"https:\\\/\\\/www.cbinsights.com\\\/company\\\/RegASK\",\"https:\\\/\\\/vimeo.com\\\/RegASK\"],\"legalName\":\"RegASK PTE. LTD.\",\"foundingDate\":\"2018\",\"slogan\":\"Empowering Smarter Regulatory Decisions\",\"description\":\"Agentic AI regulatory intelligence and workflow orchestration platform for Life Sciences and Consumer Products. RegASK combines vertical LLMs, multi-agent AI architecture, and a global community of 1,800+ subject matter experts to deliver regulatory horizon scanning, impact analysis, compliance workflow automation, and audit-ready outputs across 160+ countries.\",\"areaServed\":\"Worldwide\",\"founder\":{\"@type\":\"Person\",\"name\":\"Caroline Shleifer\",\"jobTitle\":\"Founder & CEO\"},\"address\":{\"@type\":\"PostalAddress\",\"streetAddress\":\"79 Science Park Drive, #06-01, Cintech IV\",\"addressLocality\":\"Singapore\",\"postalCode\":\"118264\",\"addressCountry\":\"SG\"},\"contactPoint\":{\"@type\":\"ContactPoint\",\"telephone\":\"+65 6817 6290\",\"contactType\":\"customer service\",\"availableLanguage\":[\"English\",\"French\",\"Japanese\",\"Spanish\",\"Chinese\",\"German\"]},\"numberOfEmployees\":{\"@type\":\"QuantitativeValue\",\"minValue\":50,\"maxValue\":100},\"knowsAbout\":[\"Regulatory Intelligence\",\"Regulatory Compliance\",\"Regulatory Affairs\",\"Workflow Orchestration\",\"Life Sciences Regulation\",\"Consumer Products Regulation\",\"AI-Driven Compliance\"],\"hasCertification\":[{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 42001:2023\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27001:2022\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27701\"},{\"@type\":\"Certification\",\"name\":\"ISO\\\/IEC 27018:2019\"},{\"@type\":\"Certification\",\"name\":\"SOC 2 Type II\"}]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/regask.com\\\/#\\\/schema\\\/person\\\/194dd7cb5a4908baaeea7bd8e3dac5d0\",\"name\":\"Divvya Behal\",\"sameAs\":[\"https:\\\/\\\/regask.com\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"Atelier 2024 de la FDA sur les m\u00e9dicaments g\u00e9n\u00e9riques\u00a0: principales informations\u00a0| RegASK","description":"L&#039;atelier 2024 de la FDA sur l&#039;avancement du d\u00e9veloppement des m\u00e9dicaments g\u00e9n\u00e9riques est essentiel pour les professionnels du secteur. D\u00e9couvrez les principaux points \u00e0 retenir avec RegASK.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/regask.com\/fr\/atelier-sur-les-medicaments-generiques-de-la-fda-2024\/","og_locale":"fr_FR","og_type":"article","og_title":"US FDA's 2024 Advancing Generic Drug Development Workshop: A Must-Attend Event for Industry Professionals","og_description":"The FDA's 2024 Advancing Generic Drug Development Workshop is essential for industry professionals. Get the key takeaways with RegASK.","og_url":"https:\/\/regask.com\/fr\/atelier-sur-les-medicaments-generiques-de-la-fda-2024\/","og_site_name":"RegASK","article_publisher":"https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","article_published_time":"2024-08-31T05:09:02+00:00","article_modified_time":"2024-09-24T18:19:23+00:00","og_image":[{"width":1600,"height":1200,"url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","type":"image\/png"}],"author":"Divvya Behal","twitter_card":"summary_large_image","twitter_creator":"@ASKRegASK","twitter_site":"@ASKRegASK","twitter_misc":{"Written by":"Divvya Behal","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#article","isPartOf":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"},"author":{"name":"Divvya Behal","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0"},"headline":"US FDA&#8217;s 2024 Advancing Generic Drug Development &hellip;","datePublished":"2024-08-31T05:09:02+00:00","dateModified":"2024-09-24T18:19:23+00:00","mainEntityOfPage":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"},"wordCount":232,"publisher":{"@id":"https:\/\/regask.com\/#organization"},"image":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","keywords":["Labelling","FDA","Regulatory Intelligence","Generic Drugs","Webinar","Workshop"],"articleSection":["Pharma and Biotech"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/","url":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/","name":"Atelier 2024 de la FDA sur les m\u00e9dicaments g\u00e9n\u00e9riques\u00a0: principales informations\u00a0| RegASK","isPartOf":{"@id":"https:\/\/regask.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"image":{"@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage"},"thumbnailUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","datePublished":"2024-08-31T05:09:02+00:00","dateModified":"2024-09-24T18:19:23+00:00","description":"L&#039;atelier 2024 de la FDA sur l&#039;avancement du d\u00e9veloppement des m\u00e9dicaments g\u00e9n\u00e9riques est essentiel pour les professionnels du secteur. D\u00e9couvrez les principaux points \u00e0 retenir avec RegASK.","inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/regask.com\/fda-2024-generic-drug-workshop\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/fda-2024-generic-drug-workshop\/#primaryimage","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/08\/us-fda-2024-advancing-generic-drug-development-workshop-must-attend-event-industry-professionals.png","width":1600,"height":1200,"caption":"Us Fda 2024 Advancing Generic Drug Development Workshop Must Attend Event Industry Professionals"},{"@type":"WebSite","@id":"https:\/\/regask.com\/#website","url":"https:\/\/regask.com\/","name":"RegASK","description":"Le syst\u00e8me d&#039;exploitation d&#039;IA r\u00e9glementaire pour les \u00e9quipes performantes","publisher":{"@id":"https:\/\/regask.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/regask.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Organization","@id":"https:\/\/regask.com\/#organization","name":"RegASK","url":"https:\/\/regask.com\/","logo":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/","url":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","contentUrl":"https:\/\/regask.com\/wp-content\/uploads\/2024\/10\/RegASK-Logo-Dark-Round.png","width":401,"height":401,"caption":"RegASK"},"image":{"@id":"https:\/\/regask.com\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/RegASKRegulatoryAffairs\/","https:\/\/x.com\/ASKRegASK","https:\/\/www.linkedin.com\/company\/RegASK\/","https:\/\/www.youtube.com\/@RegASK","https:\/\/www.crunchbase.com\/organization\/regask","https:\/\/www.bloomberg.com\/profile\/company\/1691237D:SP","https:\/\/pitchbook.com\/profiles\/company\/265004-02","https:\/\/www.cbinsights.com\/company\/RegASK","https:\/\/vimeo.com\/RegASK"],"legalName":"RegASK PTE. LTD.","foundingDate":"2018","slogan":"Empowering Smarter Regulatory Decisions","description":"Plateforme d&#039;intelligence artificielle multi-agents pour la veille r\u00e9glementaire et l&#039;orchestration des flux de travail dans le secteur des sciences de la vie et des produits de consommation. RegASK combine des LLM verticaux, une architecture d&#039;IA multi-agents et une communaut\u00e9 mondiale de plus de 1\u00a0800 experts pour fournir une veille r\u00e9glementaire, une analyse d&#039;impact, l&#039;automatisation des processus de conformit\u00e9 et des r\u00e9sultats pr\u00eats pour l&#039;audit dans plus de 160 pays.","areaServed":"Worldwide","founder":{"@type":"Person","name":"Caroline Shleifer","jobTitle":"Founder & CEO"},"address":{"@type":"PostalAddress","streetAddress":"79 Science Park Drive, #06-01, Cintech IV","addressLocality":"Singapore","postalCode":"118264","addressCountry":"SG"},"contactPoint":{"@type":"ContactPoint","telephone":"+65 6817 6290","contactType":"customer service","availableLanguage":["English","French","Japanese","Spanish","Chinese","German"]},"numberOfEmployees":{"@type":"QuantitativeValue","minValue":50,"maxValue":100},"knowsAbout":["Regulatory Intelligence","Regulatory Compliance","Regulatory Affairs","Workflow Orchestration","Life Sciences Regulation","Consumer Products Regulation","AI-Driven Compliance"],"hasCertification":[{"@type":"Certification","name":"ISO\/IEC 42001:2023"},{"@type":"Certification","name":"ISO\/IEC 27001:2022"},{"@type":"Certification","name":"ISO\/IEC 27701"},{"@type":"Certification","name":"ISO\/IEC 27018:2019"},{"@type":"Certification","name":"SOC 2 Type II"}]},{"@type":"Person","@id":"https:\/\/regask.com\/#\/schema\/person\/194dd7cb5a4908baaeea7bd8e3dac5d0","name":"Divvya Behal","sameAs":["https:\/\/regask.com"]}]}},"_links":{"self":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/7506","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/users\/22"}],"replies":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/comments?post=7506"}],"version-history":[{"count":0,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/posts\/7506\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media\/7511"}],"wp:attachment":[{"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/media?parent=7506"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/categories?post=7506"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/regask.com\/fr\/wp-json\/wp\/v2\/tags?post=7506"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}